The Supreme Court put a halt Friday to lower court rulings that would have limited a commonly used abortion medication drug, maintaining access to mifepristone while the challenge to FDA approval moves through the court system.
The order means mifepristone will still be approved for abortion up to 10 weeks of pregnancy and be used at home with distribution by mail. A lower court ruling would have limited the Food and Drug Administration’s regulation of mifepristone, a drug used in the majority of abortions in the United States.
Only Justices Samuel A. Alito Jr. and Clarence Thomas noted that they would have allowed the lower court decision to take effect.
